Amphastar Pharmaceuticals... (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

24.41

-0.09 (-0.37%)

At close: Apr 30, 2025, 3:59 PM

Amphastar Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	151.61M	144.3M	156.1M	126.35M	92.64M	73.69M	86.34M	65.59M	72.35M
Short-Term Investments	70.04M	112.51M	19.66M	10.32M	12.98M	11.68M	2.83M	2.63M	527K
Long-Term Investments	11M	15.21M	2.41M	3.98M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	25.99M	25.91M	20.86M	16.66M	5.25M	11.16M	9.92M	8.66M	9.39M
Receivables	138.04M	114.94M	88.8M	78.8M	66M	45.38M	52.16M	36M	26.78M
Inventory	153.74M	105.83M	103.58M	92.81M	96.83M	110.5M	69.32M	63.61M	79.75M
Other Current Assets	20.65M	2.96M	10.17M	2.56M	4.45M	4.47M	4.2M	10.19M	1.41M
Total Current Assets	534.07M	489.6M	378.32M	318.12M	279.68M	255.24M	220.34M	187.78M	184.1M
Property-Plant & Equipment	344.63M	315.64M	264.57M	271.49M	280.71M	253.55M	210.42M	185.34M	152.94M
Goodwill & Intangibles	590.66M	613.29M	37.3M	38.87M	40.62M	41.15M	42.27M	45.14M	50.31M
Total Long-Term Assets	1.04B	1.02B	363.67M	353.41M	351.55M	331.73M	293.22M	266.89M	243.64M
Total Assets	1.58B	1.51B	741.99M	671.53M	631.24M	586.97M	513.56M	454.67M	427.74M
Account Payables	30.51M	25.44M	20.5M	22.21M	24.36M	25.06M	31.32M	16.63M	19.93M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-56.09M	n/a	97K
Short-Term Debt	234K	436K	6.05M	5.18M	15.62M	10.92M	18.23M	6.31M	5.37M
Other Current Liabilities	n/a	168.81M	14.55M	20.18M	21.84M	7.3M	n/a	7.78M	7.71M
Total Current Liabilities	173.76M	225.41M	94.86M	103.81M	112.2M	90.01M	106.83M	67.19M	60.62M
Long-Term Debt	601.63M	589.2M	72.84M	74.38M	33.58M	38.58M	31.98M	40.84M	32.36M
Other Long-Term Liabilities	20.95M	28.78M	21.79M	22.18M	17.92M	12.86M	9.36M	7.94M	3.96M
Total Long-Term Liabilities	671.41M	648.08M	118.47M	122.2M	70.31M	69.43M	42.37M	50.14M	37.87M
Total Liabilities	845.17M	873.49M	213.33M	226.01M	182.51M	159.44M	149.2M	117.34M	98.48M
Total Debt	650.55M	623.64M	102.58M	104.66M	67.27M	66.63M	50.21M	47.16M	37.72M
Common Stock	6K	6K	6K	6K	5K	5K	5K	5K	5K
Retained Earnings	568.79M	409.27M	271.72M	180.34M	117.77M	116.37M	67.48M	76.23M	70.86M
Comprehensive Income	-9.18M	-8.48M	-8.62M	-6.76M	-3.72M	-4.69M	-4.01M	-2.1M	-4.7M
Shareholders Equity	732.3M	639.42M	528.66M	445.52M	402.31M	381.37M	332.44M	337.33M	329.25M
Total Investments	81.03M	127.72M	22.08M	14.3M	12.98M	11.68M	2.83M	2.63M	527K